105
Views
4
CrossRef citations to date
0
Altmetric
NEW METHODOLOGIES

Validation of an Experimental Model to Study Less Severe Chronic Renal Failure

, , , , , & show all
Pages 309-315 | Received 07 Jul 2015, Accepted 27 Oct 2015, Published online: 30 Mar 2016

REFERENCES

  • Khwaja A, Throssell D. A Critique of the UK NICE Guidance for the detection and management of individuals with chronic kidney disease. Nephron Clin Pract. 2009;18:207–213.
  • Eckardt KU, Coresh J, Devuyst O. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–169.
  • Chow KM, Liu ZC, Chang TM. Animal remnant kidney model of chronic renal revisited. Hong Kong J Nephrol. 2003;5:57–64.
  • Gabizon D, Goren E, Shaked U, et al. Induction of chronic renal failure in the mouse: a new model. Nephron. 1985;40:349–352.
  • Szabo AJ, Muller V, Chen GF, et al. Nephron number determines susceptibility to renal mass reduction-induced CRF in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy. Nephron Dial Transplant. 2008;23: 2492–2495.
  • Caldas HC, Fernandes IM, Kawasaki-Oyama RS, et al. Effect of stem cells seeded onto biomaterial on the progression of experimental chronic kidney disease. Exp Biol Med. 2011;236:746–754.
  • Hostetter, TH. Progression of renal disease and renal hypertrophy. Annu Rev Physiol. 1995;57:263–278.
  • Pirani CL, Salinas-Madrigal L. Evaluation of percutaneous renal biopsy. Pathol Annu. 1968;3:249–296.
  • Curtis JJ, Rakowski TA, Argy WP Jr, et al. Evaluation of percutaneous kidney biopsy in advanced renal failure. Nephron. 1976;17:259–269.
  • Coimbra TM, Janssen U, Grone HJ, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000;57:167–182.
  • Jha V, Garcia-Garcia G, Iseki K, Li Z, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
  • Gava AL, Freitas FP, Balarini CM, et al. Effects of 5/6 nephrectomy on renal function and blood pressure in mice. Int J Physiol Pathophysiol Pharmacol. 2012;4:167–173.
  • Eddy AA, Schnaper HW. Nephrotic syndrome: from the simple to the complex. Semin Nephrol. 1998;18:295–316.
  • Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005;67:404–419.
  • Li L, Huang L, Sung SS, et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia–reperfusion injury. Kidney Int. 2008;74:1526–1537.
  • Li C, Ding XY, Xiang DM, et al. Enhanced M1 and impaired M2 macrophage polarization and reduced mitochondrial biogenesis via inhibition of AMP kinase in chronic kidney disease. Cell Physiol Biochem. 2015;36:358–372.
  • Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124:139–152.
  • Abbate M, Zoja C, Corna D, et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol. 2008;19: 1158–1167.
  • Speyer CL1, Ward PA. Role of endothelial chemokines and their receptors during inflammation. J Invest Surg. 2011;24:18–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.